Clinical Trials Logo

Infection clinical trials

View clinical trials related to Infection.

Filter by:

NCT ID: NCT02882360 Not yet recruiting - Obesity Clinical Trials

Kerlix for Pregnant Women With Elevated BMI to Prevent Wound Infection by 6 Weeks Post Partum

Start date: October 2016
Phase: Phase 4
Study type: Interventional

Pregnant women with BMI>40 will be approached for participation in a study to reduce the rate of post-operative wound infection from C-section. Women will be randomized to a commonly used wound product (Kerlix-AMD) which consists of a PHMB-impregnated gauze versus normal gauze, and rates of post-operative surgical site infection will be assessed. Women with a planned procedure will also be randomized to applying Kerlix versus gauze for 3 days pre-operatively to determine if this improves outcomes as well.

NCT ID: NCT02869204 Not yet recruiting - Clinical trials for Wound Infection and Wound Healing

The Effect of a Local Injection of a Platelet Concentrate on Infection and Healing of Surgical Wounds

Start date: September 2016
Phase: N/A
Study type: Interventional

The purpose of this project is to investigate whether a combination of a local injection of platelet rich plasma (PRP) combined with a daily supplement of vitamin C, zinc, L-arginine, as well as high protein diet (1.5 g of protein per kilo body weight per day) can promote tissue healing in patients undergoing open upper-abdominal surgery. Primary endpoint is cases of wound infection and secondary endpoints are time of tissue regeneration (days), judged by traditional clinical observation and experimentally assessed by ultrasound. The experiment is performed as a parallel two-armed, randomized, controlled trial. A total of 40 subjects will be included in the trial i order to ensure the power of the study, despite a drop off of up to 25%.

NCT ID: NCT02868372 Not yet recruiting - Wound Infection Clinical Trials

Swabbing of Subcutaneous Tissues of Cesarean Section Wounds With Povidone Iodine

Start date: September 2016
Phase: N/A
Study type: Interventional

The study has 2 groups. Group A in which the subcutaneous tissue will be swabbed with 10 cc of undiluted 10% povidone iodine and will not be mobbed. Group B ; No swabbing. Women in both groups will be followed up during hospital stay and outpatient clinic visits a week and a month after cesarean delivery for surgical site complications which will be evaluated by the researcher.

NCT ID: NCT02856529 Not yet recruiting - Clinical trials for Infection Control Training

Effects of Basic Infection Control Skills License on Knowledge and Practice of Health Care Workers

Start date: June 2016
Phase: N/A
Study type: Interventional

Considering the importance of infection control practices, Madinah Public Health Department launched a new license program for healthcare workers, the Basic Infection Control Skills License program (BICSL). BICSL has been launched to train healthcare workers all over the region in a scientific standardized way. To assess BICSL effectiveness, a non-randomized control study will be conducted in two of the general hospitals in Madinah. An electronic bilingual self-administrated valid and reliable questionnaire will be used to evaluate the workers knowledge and practices before and after three and six months of the intervention. The knowledge and practice answers were scored and the scores were categorized to facilitate the comparison. A BICSL certified trainer will be conducting the intervention, a one to one training session. A SPSS program will be used to analyze the data. Administrative and ethical approval was obtained from Madinah health authority. The participants will complete an electronic consent before they fill the questionnaire. Confidentiality and privacy as well as freedom to participate or not will be insured to all participants. This study will assess the license effectiveness in improve knowledge and compliance.

NCT ID: NCT02825381 Not yet recruiting - Infection Clinical Trials

One-Stage Exchange for Chronically Infected Total Hip Arthroplasty

Start date: July 2016
Phase: N/A
Study type: Observational

The primary goal of the study is to evaluate the success rate of routine one-stage exchange for treatment of chronically infected total hip arthroplasty performed at the investigators institution, and to compare it to the current literature reporting success rate of selected one-stage exchange procedure or two-stage procedure. The secondary goal is to detect the potential prognostic factors and potential selection criteria which may influence the success rate. The tested hypothesis is following: the success rate of routine one-stage exchange is lower than that of selected one-stage or two-stage procedure

NCT ID: NCT02808299 Not yet recruiting - Liver Injury Clinical Trials

Liver Injury by Statins in Patients With History of Hepatitis B Virus Infection

LISHBV
Start date: December 2016
Phase: N/A
Study type: Observational

The purpose of this study is to investigate the incidence of liver injury by statins in coronary heart disease (CHD) patients with history of hepatitis B virus (HBV) infection.

NCT ID: NCT02779296 Not yet recruiting - Clinical trials for Surgical Wound Infection

Trial Investigating Cyanoacrylate Glue to Prevent Surgical Site Infection Following Breast Surgery

Start date: June 2016
Phase: Phase 4
Study type: Interventional

Surgical Site Infections (SSI) represents a significant complication in plastic surgery. Infections can result in a prolonged recovery and impair long-term cosmetic appearance. One potential method to reduce infection is by applying a thin layer of dermal glue over the sutures at the site of incision immediately after the surgery. Conventional closures, such as sutures or staples, leave the site vulnerable until epithelialization occurs in 24 to 48 hours. In contrast, dermal glue provides an instant, waterproof barrier and it has been shown to have intrinsic bacteriostatic properties. The glue is supplied as a liquid enclosed in a vial and when applied, polymerizes rapidly in an exothermic reaction in the presence of moisture to form a solid adhesive. 2-Octylcyanoacrylate (2-OCA)-based glue is formulated to be more flexible than previous preparations. The application of dermal glue is rapid, simple and requires no specific follow-up as it naturally sloughs off overtime. The purpose of this study is to determine if 2-OCA-based glue can reduce the rate of surgical site infection following surgery. Patients undergoing breast surgery will be recruited and randomized to either a group receiving a layer of glue over sutures following surgery or no treatment. Patients will be followed up at 30 days and at 8 months for signs of infection, additional complications and the visual appearance of the scars. The cost of treating and infection will be calculated to determine if using dermal glue to prevent infection is economically feasible. This research has the potential to find a method to reduce surgical site infection, which can be applied to other surgeries.

NCT ID: NCT02715037 Not yet recruiting - Clinical trials for Infectious Mononucleosis

Microbiology of Severe Acute Tonsillitis, Peritonsillar Cellulitis, and Infectious Mononucleosis

Start date: June 2016
Phase: N/A
Study type: Observational

Prospective, observational study of the microbiology of patients referred to a tertiary care center with severe acute tonsillitis, peritonsillar cellulitis, or infectious mononucleosis.

NCT ID: NCT02693639 Not yet recruiting - Infection Clinical Trials

Prediction Value of PANX1 in Infection Post Liver Transplantation

Start date: February 2016
Phase: N/A
Study type: Observational

The purpose of this study is to determine prediction value of PANX1 expression in infection post liver transplantation.

NCT ID: NCT02686645 Not yet recruiting - Clinical trials for Clostridium Difficile Infection

Fecal Microbiota Therapy for Recurrent Clostridium Difficile Infection

Start date: December 2016
Phase: Phase 2/Phase 3
Study type: Interventional

Interventional, single arm, single-centre trial to evaluate the effectiveness and safety of fecal microbiota therapy (FMT) in the investigators population.